Differential immune response to gangliosides in Guillain-Barré syndrome patients from Japan and The Netherlands
- 1 December 2001
- journal article
- research article
- Published by Elsevier BV in Journal of Neuroimmunology
- Vol. 121 (1-2), 83-87
- https://doi.org/10.1016/s0165-5728(01)00426-x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Molecular Characterization of Campylobacter jejuni from Patients with Guillain-Barré and Miller Fisher SyndromesJournal of Clinical Microbiology, 2000
- Rapidly progressive, predominantly motor Guillain-Barré syndrome with anti-GalNAc-GD1a antibodiesNeurology, 1999
- Anti-GalNAc-GD1a antibody-associated Guillain-Barré syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbanceAnnals of Neurology, 1999
- Anti‐GD1a antibody is associated with axonal but not demyelinating forms of Guillain‐Barré syndromeAnnals of Neurology, 1999
- Antibodies to gangliosides and galactocerebroside in patients with Guillain–Barré syndrome with preceding Campylobacter jejuni and other identical infectionsJournal of Neuroimmunology, 1998
- Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barre syndrome.Journal of Neurology, Neurosurgery & Psychiatry, 1997
- Campylobacter jejuni infections and anti‐GM1 antibodies in guillain‐barré syndromeAnnals of Neurology, 1996
- Guillain-Barré syndrome in northern China Relationship to Campylobacter jejuni infection and anti-glycolipid antibodiesBrain, 1995
- Serum anti‐GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndromeAnnals of Neurology, 1995
- Assessment of current diagnostic criteria for Guillain-Barr syndromeAnnals of Neurology, 1990